Perspective on the economic evaluation of deep brain stimulation

Frontiers in Integrative Neuroscience

Volumn 5, Issue , 2011, Pages

  McIntosh, Emma Sarah ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Broad perspective; Deep brain stimulation; Economic evaluation; Parkinson's disease perspective on the economic evaluation of deep brain stimulation; Time horizon

Indexed keywords

ANTIBIOTIC AGENT; APOMORPHINE;

ARTICLE; BLEEDING; BRAIN DEPTH STIMULATION; COMMUNITY CARE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG COST; ECONOMIC EVALUATION; EQUIPMENT DESIGN; FOLLOW UP; HEALTH CARE COST; HEALTH ECONOMICS; HOME CARE; HUMAN; HUMERUS FRACTURE; INSTITUTIONALIZATION; LENGTH OF STAY; MOTOR PERFORMANCE; ODONTOID PROCESS FRACTURE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PELVIS FRACTURE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SOCIAL CARE; STROKE; SURGICAL INFECTION; SURGICAL RISK; THERAPY EFFECT; WRIST FRACTURE;

EID: 82255177108     PISSN: 16625145     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnint.2011.00019     Document Type: Article

References (40)

1. Bowling, A. (1991). Measuring Health: A Review of Quality of Life Measurement Scales. Buckingham: Open University Press.
2. Bowling, A. (1995). Measuring Disease. Buckingham: Open University Press.
3. Briggs, A. H. (2001). "Handling uncertainty in economic evaluation and presenting the results," in Economic Evaluation in Health Care: Merging Theory with Practice, eds M. F. Drummond and A. McGuire (Oxford: Oxford University Press), 172-214.
4. Brouwer, W., Rutten, F., and Koopmanschap, M. A. (2001). "Costing in economic evaluations," in Economic Evalaution in Health Care: Merging Theory with Practice, eds M. F. Drummond and A. McGuire (Oxford: Oxford University Press), 68-93.
5. Buckingham, K. (1993). A note on HYE (Healthy Years Equivalents). J. Health Econ. 12, 301-309.
6. Buckingham, K. (1995). Economics, health and health economics - HYEs versus QALYs-a response. J. Health Econ. 14, 397-398.
7. Coast, J., Flynn, T., Natarajan, L., Sproston, K., Lewis, J., and Jea, L. J. (2008a). Valuing the ICECAP capability index for older people. Soc. Sci. Med. 67, 874-882.
8. Coast, J., Smith, R., and Lorgelly, P. (2008b). Should the capability approach be applied in health economics? Health Econ. 17, 667-670.
9. Culyer, A. J. (1989). The normative economics of health care finance and provision. Oxf. Rev. Econ. Pol. 5, 34-58.
10. De Meijer, C., Brouwer, W., Koopmanschap, M., Van den berg, B., and Van Exel, J. (2010). The value of informal care - a further investigation of the feasibility of contingent valuation in informal caregivers. Health Econ.19, 755-771.
11. Dolan, P., Gudex, C., Kind, P., and Williams, A. (1995). A Social Tariff for EuroQol: Results from a UK General Population Survey. York: University of York.
12. Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B., and Stoddart, G. L. (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
13. Drummond, M. F., Stoddard, G. L., and Torrance, W. (1987). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
14. Glick, H., Doshi, J. A., Sonnad, S. S., and Polsky, D. (2007). Economic Evaluation in Clinical Trials. Oxford: Oxford University Press.
15. Gold, M. R., Siegel, J. E., Russell, L. B., and Weinstein, M. C. (1996). Cost- effectiveness in Health and Medicine. New York: Oxford University Press.
16. Grewal, I., Lewis, J., Flynn, T., Brown, J., Bond, J., and Coast, J. (2006). Developing attributes for a generic quality of life measure for older people: preferences or capabilities? Soc. Sci. Med. 62, 1891-1901.
17. HM Treasury (2003). The Green Book: Appraisal and Evaluation in Central Government, London: TSO, UK.
18. Hoehn, M., and Yahr, M. (1967). Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
19. Jenkinson, C., Fitzpatrick, R., Peto, V., Harris, R., and Saunders, P. (2008). The Parkinson's Disease Questionnaire PDQ-39 User Manual. Oxford: University of Oxford.
20. Joint Formulary Committee. (2010) British National Formulary, 60 Edn. London: British Medical Association and Royal Pharmaceutical Society.
21. Joint, C., Nandi, D., Parkin, S., Gregory, R., and Aziz, T. (2002). Hardware-related problems of deep brain stimulation in 100 consecutive electrodes. Mov. Disord. 17(Suppl. 3), S175-S180.
22. Koopmanschap, M. A., Rutten, F., van Ineveld, B. M., and van Roijen, L. (1997). The friction cost method for measuring indirect costs of disease. J. Health Econ. 6, 253-259.
23. McIntosh, E., Clarke, P., Frew, E., and Louviere, J. J. (2010). Applied Methods of Cost Benefit Analysis in Health Care. Oxford: Oxford University Press.
24. Movement Disorders Centre UoF. (2011). Movement Disorders Centre (MDC).
25. Nussbaum, M. (2003). Capabilities as fundamental entitlements: Sen and social justice. Fem. Econ. 9, 33-59.
26. Pritchard, C., and Sculpher, M. (2000). Productivity Costs: Principles and Practice in Economic Evaluation. London: Office of Health Economics.
27. Ramzi, D. W., and Leeper, K. V. (2004). DVT and pulmonary embolism: Part II. Treatment and prevention. Am. Fam. Physician 69, 2841-2848.
28. Rice, D. P., and Cooper, B. S. (1967). The economic value of human life. Am. J. Public Health 57, 1954-1966.
29. Richardson, J. (1994). Cost utility analysis - what should be measured? Soc. Sci. Med. 39, 7-21.
30. Sackett, D. L., and Torrance, G. W. (1978). The utility of different health states as perceived by the general public. J. Chronic Dis. 31, 697-704.
31. Sen, A. (1993). "Capability and well-being," in The Quality of Life, eds M. Nussbaum and A. sen (Oxford: Clarendon Press), 30-53.
32. The EuroQol Group. (2011). EQ-5D Home Page. Available at: www.euroqol.org
33. Torrance, G. W. (1976). Social preferences for health states: an empirical evalua-tion of three measurement techniques. Socioecon. Plan. Sci. 10, 128-136.
34. Torrance, G. W., Boyle, M. H., and Horwood, S. P. (1982). Application of multiattribute utility theory to measure social preferences for health states. Oper. Res. 30, 1043-1069.
35. Torrance, G. W., and Sackett, D. L. (1972). A utility maximising model for evaluation of health care programmes. Health Serv. Res. 7, 118-133.
36. Van Buuren, S., Boshuizen, H. C., and Knook, D. L. (1999). Multiple imputation of missing blood pressure covariates in survival analysis. Stat. Med. 18, 681-694.
37. Van den berg, B., and Ferrer-I-Cabonell, A. (2007). Monetary valuation of informal care: the well-being valuation method. Health Econ. 16, 1227-1244.
38. Van Houtven, C. N., and Norton, E. C. (2004). Informal care and health care use of older adults. J. Health Econ. 23, 1159-1180.
39. Williams, A. (1985). Economics of coronary artery bypass grafting. Br Med J 291, 326-329.
40. Williams, A., Gill, S., varma, T., Jenkinson, C., Quinn, N., mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., Patel, S., Wheatley, K., and PD SURG Collaborative Group. (2010). Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's Disease (PDSURG Trial): a randomised, open-label trial. Lancet Neurol. 9, 581-591.